Advertisement

Intermittent hypoxic training: doping or what?

  • Giuseppe LippiEmail author
  • Massimo Franchini
Letter to the Editor

Keywords

Intermittent Hypoxia Endurance Athlete Hypobaric Hypoxia Recombinant Human Erythropoietin Hypoxic Treatment 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Conflict of interest statement

None of the authors had any conflicts of interest with the funding agencies or professional relationships with companies or manufacturers who may benefit from the results of the present study.

References

  1. Dicato M (2008) Venous thromboembolic events and erythropoiesis-stimulating agents: an update. Oncologist 13(Suppl 3):11–15CrossRefPubMedGoogle Scholar
  2. Heinicke K, Prommer N, Cajigal J, Viola T, Behn C, Schmidt W (2003) Long-term exposure to intermittent hypoxia results in increased hemoglobin mass, reduced plasma volume, and elevated erythropoietin plasma levels in man. Eur J Appl Physiol 88:535–543CrossRefPubMedGoogle Scholar
  3. Levine BD (2002) Intermittent hypoxic training: fact and fancy. High Alt Med Biol 3:177–193CrossRefPubMedGoogle Scholar
  4. Lippi G, Banfi G (2006) Blood transfusions in athletes. Old dogmas, new tricks. Clin Chem Lab Med 44:1395–1402CrossRefPubMedGoogle Scholar
  5. Lippi G, Guidi G (2000) Laboratory screening for erythropoietin abuse in sport: an emerging challenge. Clin Chem Lab Med 38:13–19CrossRefPubMedGoogle Scholar
  6. Lippi G, Franchini M, Salvagno GL, Guidi GC (2006) Biochemistry, physiology, and complications of blood doping: facts and speculation. Crit Rev Clin Lab Sci 43:349–391CrossRefPubMedGoogle Scholar
  7. Lippi G, Franchini M, Guidi GC (2007) Prohibition of artificial hypoxic environments in sports: health risks rather than ethics. Appl Physiol Nutr Metab 32:1206–1207CrossRefPubMedGoogle Scholar
  8. McKoy JM, Stonecash RE, Cournoyer D, Rossert J, Nissenson AR, Raisch DW, Casadevall N, Bennett CL (2008) Epoetin-associated pure red cell aplasia: past, present, and future considerations. Transfusion 48:1754–1762CrossRefPubMedGoogle Scholar
  9. Sanchis-Gomar F, Martinez-Bello VE, Domenech E, Nascimento AL, Pallardo FV, Gomez-Cabrera MC, Vina J (2009) Effect of intermittent hypoxia on hematological parameters after recombinant human erythropoietin administration. Eur J Appl Physiol (Epub ahead of print)Google Scholar
  10. Wang JS, Chen LY, Fu LL, Chen ML, Wong MK (2007) Effects of moderate and severe intermittent hypoxia on vascular endothelial function and haemodynamic control in sedentary men. Eur J Appl Physiol 100:127–135CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2009

Authors and Affiliations

  1. 1.Sezione di Chimica Clinica, Dipartimento di Scienze Morfologico-BiomedicheUniversità di VeronaVeronaItaly
  2. 2.Servizio di Immunoematologia e TrasfusioneAzienda Ospedaliero, Universitaria di ParmaParmaItaly

Personalised recommendations